Nippon Carbon Q1 FY2026 Outlook: Investment Phase Pressures Profits Despite Revenue Growth
Nippon Carbon Co., Ltd. (TSE:5302), a leading manufacturer of carbon products for semiconductors, aerospace, and battery applications, reported
Earnings
Ono Pharmaceutical Lifts Operating Profit 54% on Portfolio Shift; FY2027 Guidance Signals Margin Defense
Ono Pharmaceutical Co., Ltd. (TSE:4528), a mid-tier Japanese pharmaceutical manufacturer with a high concentration of expiring patents, reported full-year
Original Design Co., Ltd. Q1 Forecast: Infrastructure Tailwinds Support 28% Revenue Surge
Original Design Co., Ltd. (TSE:4642), a construction consulting and water infrastructure specialist serving Japanese municipalities, delivered
Sanyo Industries Outlook: Profit Decline Continues as Construction Demand Softens
Sanyo Industries Co., Ltd. (TSE:5958), a specialized manufacturer of ceiling, floor, and wall substrate materials for Japan's construction sector,
Sockets Inc. Swings to Profit on Operational Efficiency; FY2027 Guidance Points to Margin Expansion
Sockets Inc. (TSE:3634), a mobile search and content recommendation platform operator, has returned to profitability in fiscal year 2026 (ended March
Sumiseki Holdings Co., Ltd. FY2026 Analysis: Operating Profit Surge Masks Non-Operating Drag
Sumiseki (TSE:1514) Holdings Co., Ltd. FY2026 Analysis: Operating Profit Surge Masks Non-Operating Drag
Techno Horizon Lifts FY2027 Forecast on Dramatic Margin Recovery
Techno Horizon Co.,Ltd. (TSE:6629), a diversified technology company applying video, IT, and robotics expertise across education, healthcare, and factory
Toba Yoko Lifts FY2027 Forecast on Margin Recovery Amid Semiconductor Rebound
Toba Yoko Co., Ltd. (TSE:7472), a specialized machinery and tools distributor, reported a challenging fiscal year ended March 2026, with revenue declining
Tokyo Electron Lifts FY2027 Forecast on Demand Recovery
Tokyo Electron Limited (TSE:8035), the world's leading supplier of semiconductor manufacturing equipment with particular strength in front-end process
Transgenic Group Inc. Lifts FY2027 Forecast on M&A Integration Gains
Transgenic Group Inc. (TSE:2342), a drug discovery research support venture specializing in mouse-based genetic analysis, returned to operating